Skip to main content

Table 1 The relationship between clinicopathological characteristics and mucinous adenocarcinoma in stage I colorectal cancer

From: Survival after curative resection for stage I colorectal mucinous adenocarcinoma

Variable MAC (n = 58) Non-MAC (n = 472) p value
Sex    
 Male 34 (58.6%) 255 (54.0%) 0.508
 Female 24 (41.4%) 217 (46.0%)  
Age    
 ≤ 65 40 (69.0%) 291 (61.7%) 0.278
 > 65 18 (31.0%) 181 (38.3%)  
Preoperative CEA    
 ≤ 5 ng/dL 53 (91.4%) 413 (87.5%) 0.393
 > 5 ng/dL 5 (8.6%) 59 (12.5%)  
T classification    
 1 8 (13.8%) 162 (34.3%) 0.002*
 2 50 (86.2%) 310 (65.7%)  
Location    
 Colon 24 (41.4%) 136 (28.8%) 0.049*
 Rectal 34 (58.6%) 336 (71.2%)  
Size    
 < 3 cm 28 (48.3%) 281 (59.5%) 0.101
 ≥ 3 cm 30 (51.7%) 191 (40.5%)  
LVI    
 (−) 54 (93.1%) 457 (96.8%) 0.151
 (+) 4 (6.9%) 15 (3.2%)  
Less than 12 lymph nodes    
 Yes 10 (17.2%) 87 (18.4%) 0.825
 No 48 (82.8%) 385 (81.6%)  
dMMR    
 Yes 7 (12.1%) 14 (3.0%) 0.001*
 No 51 (87.9%) 458 (97.0%)  
  1. The bold and *  indicates p < 0.05
  2. MAC mucinous adenocarcinomas, CEA carcinoembryonic antigen, dMMR deficient mismatch repair